Sole Source Capital Acquires Westwood Laboratories
Discover Sole Source Capital's strategic move into contract manufacturing with the acquisition of Westwood Laboratories. Learn how this expansion taps into diverse markets, offering full-service solutions for consumer staple products.
DALLAS–Sole Source Capital LLC (“SSC”), an industrial-focused private equity firm, announced that it has acquired Westwood Laboratories (“Westwood”), a contract manufacturer of consumer staple products in the beauty, personal care, pet and over-the-counter drug end markets. This is Sole Source Capital’s first investment in the contract manufacturing industry. Terms of the transaction were not disclosed.
Founded in 1948 in Azusa, California, Westwood provides a full-service contract manufacturer offering including formulation design, research & development, compounding, filling, packaging and overwrapping/bagging. The company serves a diverse group of established consumer brands in addition to fast-growing emerging brands. Westwood specializes in liquids, creams, gels and pastes that are packaged in a variety of formats.
“We were attracted to Westwood’s ability to provide a full-service product offering in the contract manufacturing space to a diverse mix of established and emerging consumer brands in the recession-resilient personal care, pet, and over-the-counter drug end markets. The company employs an impressive formulary team of industry veterans with decades of experience in developing cutting-edge products,” said David Fredston, Founder and CEO of Sole Source Capital. “Additionally, we believe the contract manufacturing industry has been exhibiting strong secular tailwinds – offering significant growth potential for the company – and are excited to be entering this expanding space.”
For more information, checkout SSC acquires Westwood Labs.
What's Your Reaction?
